PETQ PetIQ Inc. Class A

PetIQ, Inc. Launches Telehealth Platform for Pet Parents

PetIQ, Inc. Launches Telehealth Platform for Pet Parents

EAGLE, Idaho, May 12, 2020 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced the launch of its telehealth service in partnership with whiskerDocs, a leader in the veterinary telehealth industry that has been at the forefront of establishing best practices in veterinary telehealth since 2013.

Dr. Lauren Olavessen, PetIQ’s Chief Medical Officer, commented, “The health of our customers’ pets is our number one concern. Offering a comprehensive telehealth solution is the natural extension of our commitment to provide affordable and convenient pet wellness products and services. We look forward to seeing our valued customers when our Wellness Centers and Community Clinics resume operations, and although telehealth cannot replace an in-person physical exam, we are excited to provide our customers with more support.”

The telehealth service is complimentary and available to PetIQ’s loyal pet parents who have visited one of its service locations in the past.  Customers can utilize the PetIQ Veterinary Help Line, powered by whiskerDocs, seven days a week, from 7am to 7pm, and speak to a team of veterinary professionals to assist with common questions pet parents have about general pet care, including topics such as the triage of symptoms, education and information on testing & prevention, behavioral issues, diet & exercise, and holistic health options.

Further, the PetIQ family of veterinary service brands, including VetIQ Petcare, VIP Petcare, and PetVet, is developing expanded capabilities in a second phase that will offer customers a more comprehensive, integrative care solution. The solution will combine the teletriage and decision support services provided by whiskerDocs with a telemedicine platform that will be available on a state-by-state basis, depending upon prevailing regulations and the services the Company can provide in a virtual setting.

Deb Leon, Chief Executive Office of whiskerDocs, added, “We are pleased to partner with PetIQ because we share a common mission to provide pet parents the access they need to clinical and educational resources, delivered in an integrated system that elevates their confidence and ability to care for their pets. Together, the blending of whiskerDocs’ teletriage service and PetIQ’s affordable, convenient nationwide solutions empowers pet parents to make better decisions on behalf of their pets.”

About PetIQ

PetIQ is a leading pet medication and wellness company delivering a smarter way for pet parents to help their pets live their best lives through convenient access to affordable veterinary products and services.  The company engages with customers through more than 60,000 points of distribution across retail and e-commerce channels with its branded distributed medications, which is further supported by its own world-class medications manufacturing facility in Omaha, Nebraska.  The company’s national service platform, VIP Petcare, operates in over 3,400 retail partner locations in 41 states providing cost effective and convenient veterinary wellness services.  PetIQ believes that pets are an important part of the family and deserve the best products and care we can give them.  For more information, visit .

About whiskerDocs

whiskerDocs, the leader in virtual triage services for pets, has been trailblazing telehealth with innovative on-demand solutions since 2013. Serving pet parents in the U.S. and Canada, whiskerDocs provides multi-channel access to nearly 5 million pets via client partnerships and direct to consumer relationships. whiskerDocs’ team of veterinary telehealth specialists is comprised of licensed veterinarians and credentialed veterinary technicians, who are enabled to deliver a seamless experience with primary care providers through whiskerDocs’ patented processes and proprietary technology.

Contact:

Investor Relations Contact:Media Relations Contact:
ICR

Jeff Sonnek

646-277-1263

ICR

Cory Ziskind

646-277-1232

EN
12/05/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetIQ Inc. Class A

 PRESS RELEASE

PetIQ Names Camillo Pane as Chief Executive Officer

PetIQ Names Camillo Pane as Chief Executive Officer Accomplished Consumer Goods and Health Care LeaderWould Bring Decades of Leadership Experience to Role EAGLE, Idaho, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”), a leading pet medication, health and wellness company and portfolio company of Bansk Group, is pleased to announce that Camillo Pane would join PetIQ as Chief Executive Officer, effective February 17, 2025. Mr. Pane would succeed Cord Christensen. Mr. Pane’s passion for making a difference in the lives of consumers has been a constant focus through...

 PRESS RELEASE

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Gr...

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion. PetIQ stockholders will receive $31.00 in cash per PetIQ share in accordance with the terms of the tran...

 PRESS RELEASE

PetIQ, Inc. Announces Results of Special Meeting of Stockholders

PetIQ, Inc. Announces Results of Special Meeting of Stockholders Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 EAGLE, Idaho, Oct. 22, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, announced today that at its virtual Special Meeting of Stockholders approximately 80% of its outstanding shares of common stock voted to approve the adoption of the definitive merger agreement (the “Agreement”) pursuant to which Bansk Group will acquir...

 PRESS RELEASE

PetIQ, Inc. Reports Second Quarter 2024 Financial Results

PetIQ, Inc. Reports Second Quarter 2024 Financial Results Generates Record Second Quarter 2024 Net Sales and Net IncomeRecord Adjusted EBITDA of $39.0 Million Exceeds Company's Second Quarter 2024 GuidancePetIQ and Bansk Group Sign Definitive Merger Agreement EAGLE, Idaho, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, product and wellness company, today reported financial results for the second quarter and six months ended June 30, 2024. Cord Christensen, PetIQ’s Founder and CEO, commented, “We are ...

 PRESS RELEASE

PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk G...

PetIQ, Inc. Enters into Definitive Agreement to be Acquired by Bansk Group PetIQ Stockholders to Receive $31.00 Per Share in an All-Cash Transaction Valued at Approximately $1.5 Billion EAGLE, Idaho, and NEW YORK, New York, Aug. 07, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, and Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, today announced that PetIQ entered into a definitive agreement (the “Agreement”) pursuant to which Bansk...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch